HB Wealth Management LLC Acquires 43,202 Shares of Haleon PLC Sponsored ADR $HLN

Key Points

• HB Wealth Management LLC increased its ownership of Haleon PLC shares by 47.2% during the 2nd quarter, now holding a total of 134,796 shares valued at approximately $1.4 million.
• Haleon recently announced a semi-annual dividend of $0.0555, up from $0.05, showcasing a yield increase of 190.0% with a payout ratio of 28.21%.
• Analysts have varied opinions on Haleon stock, with Barclays downgrading it to "equal weight" while Goldman Sachs upgraded it to "buy," reflecting a consensus average target price of $12.33.

HB Wealth Management LLC lifted its holdings in shares of Haleon PLC Sponsored ADR (NYSE:HLN - Free Report) by 47.2% during the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 134,796 shares of the company's stock after purchasing an additional 43,202 shares during the period. HB Wealth Management LLC's holdings in Haleon were worth $1,398,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in HLN. Nuveen LLC bought a new stake in shares of Haleon during the first quarter worth $58,870,000. Millennium Management LLC grew its holdings in shares of Haleon by 697.2% during the first quarter. Millennium Management LLC now owns 4,216,504 shares of the company's stock worth $43,388,000 after purchasing an additional 3,687,613 shares during the last quarter. Wellington Management Group LLP grew its holdings in shares of Haleon by 22.0% during the first quarter. Wellington Management Group LLP now owns 18,700,480 shares of the company's stock worth $192,428,000 after purchasing an additional 3,372,155 shares during the last quarter. Sculptor Capital LP grew its holdings in shares of Haleon by 22.1% during the first quarter. Sculptor Capital LP now owns 10,849,868 shares of the company's stock worth $111,645,000 after purchasing an additional 1,962,770 shares during the last quarter. Finally, Jane Street Group LLC grew its holdings in shares of Haleon by 933.1% during the first quarter. Jane Street Group LLC now owns 2,155,716 shares of the company's stock worth $22,182,000 after purchasing an additional 1,947,050 shares during the last quarter. Institutional investors own 6.67% of the company's stock.

Haleon Trading Down 1.4%

Shares of HLN opened at $8.89 on Friday. The company has a quick ratio of 0.63, a current ratio of 0.87 and a debt-to-equity ratio of 0.48. Haleon PLC Sponsored ADR has a 12-month low of $8.71 and a 12-month high of $11.42. The firm has a market capitalization of $39.69 billion, a PE ratio of 22.78, a price-to-earnings-growth ratio of 2.67 and a beta of 0.20. The stock's fifty day simple moving average is $9.51 and its 200-day simple moving average is $10.08.

Haleon Increases Dividend

The business also recently announced a semi-annual dividend, which was paid on Thursday, September 18th. Shareholders of record on Friday, August 15th were paid a $0.0555 dividend. The ex-dividend date of this dividend was Friday, August 15th. This is a positive change from Haleon's previous semi-annual dividend of $0.05. This represents a yield of 190.0%. Haleon's payout ratio is currently 28.21%.

Analysts Set New Price Targets

Several analysts have recently commented on HLN shares. Barclays cut Haleon from an "overweight" rating to an "equal weight" rating in a report on Tuesday, September 16th. The Goldman Sachs Group raised Haleon from a "neutral" rating to a "buy" rating in a research note on Wednesday, September 10th. Finally, Wall Street Zen lowered Haleon from a "buy" rating to a "hold" rating in a research note on Saturday, July 12th. One investment analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and five have issued a Hold rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $12.33.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.